QuidelOrtho Cash Flow Statement
NASDAQ: QDELHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
13.42+1.01 (+8.14%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QuidelOrtho free cash flow
In fiscal 2025, QuidelOrtho generated $105.2 million of operating cash flow and spent $188.2 million on capital expenditures. That left free cash flow of -$83.0 million, a free-cash-flow margin of -3.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
QuidelOrtho cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20222022-01-02 | FY 20212021-01-03 |
|---|---|---|---|---|---|---|
| Net Income | -1.13B | -2.05B | -10.10M | 548.70M | 704.20M | 810.30M |
| Net Income growth (YoY) | — | — | -101.84% | -22.08% | -13.09% | — |
| Depreciation & Amortization | 442.00M | 453.40M | 457.20M | 283.60M | 52.70M | 48.80M |
| Stock-Based Compensation | 45.90M | 42.10M | 51.60M | 48.40M | 25.40M | 21.00M |
| Change in Working Capital | -133.80M | -174.70M | -54.50M | -18.40M | 72.20M | -390.60M |
| Operating Cash Flow | 105.20M | 83.00M | 280.20M | 885.30M | 805.90M | 629.70M |
| Capital Expenditures | -188.20M | -195.10M | -209.30M | -140.90M | -292.80M | -64.90M |
| Investing Cash Flow | -192.70M | -149.90M | -187.60M | -1.64B | -319.50M | -63.30M |
| Share Repurchases | 0 | 0 | -7.20M | -74.30M | -103.50M | -43.70M |
| Debt Issued | 2.56B | 0 | 0 | 2.73B | 0 | 0 |
| Debt Repaid | -2.29B | -143.00M | -228.00M | — | — | — |
| Financing Cash Flow | 155.80M | 48.80M | -265.80M | 252.00M | -173.10M | -130.30M |
| Net Change in Cash | 71.30M | -21.00M | -174.40M | -508.90M | 312.90M | 437.10M |
| Free Cash Flow | -83.00M | -112.10M | 70.90M | 744.40M | 513.10M | 564.80M |
This table shows 6 annual periods of QuidelOrtho's cash flow statement, from FY 2025 back to FY 2021, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow QDEL's reporting calendar. What is a cash flow statement?